Mapping of ACE2 binding site on SARS-CoV-2 spike protein S1: docking study with peptides

Mapping of ACE2 binding site on SARS-CoV-2 spike protein S1: docking study with peptides

Among different approaches to control the COVID-19 disease, there is clear interest to develop inhibitors which block the virus interaction with the host cells and through this simple mechanism could facilitate developing medication. In this report, interaction of the virus SARS CoV-2 spike protein...

Full description

Bibliographic Details
Main Authors:	Jaak Järv, Aleksei Kuznetsov
Format:	Article
Language:	English
Published:	Estonian Academy Publishers 2020-06-01
Series:	Proceedings of the Estonian Academy of Sciences
Subjects:	sars-cov-2 virus spike protein s1 binding site mapping peptide docking covid-19 treatments.
Online Access:	https://kirj.ee/wp-content/plugins/kirj/pub/proc-2020-3-228-234_20200731141118.pdf

Similar Items

Mapping the ACE2 binding site on the SARS-CoV-2 spike protein S1: molecular recognition pattern
by: Aleksei Kuznetsov, et al.
Published: (2020-10-01)

Docking and Molecular Dynamics Simulations Clarify Binding Sites for Interactions of Novel Marine Sulfated Glycans with SARS-CoV-2 Spike Glycoprotein
by: Priyanka Samanta, et al.
Published: (2023-09-01)

Ligand structure controlled allostery in cAMP-dependent protein kinase catalytic subunit
by: Kuznetsov Aleksei, et al.
Published: (2009-06-01)

Development of SARS-CoV-2 Inhibitors Using Molecular Docking Study with Different Coronavirus Spike Protein and ACE2
by: Israa Mohamed Shamkh, et al.
Published: (2021-06-01)

Improved Modeling of Peptide-Protein Binding Through Global Docking and Accelerated Molecular Dynamics Simulations
by: Jinan Wang, et al.
Published: (2019-10-01)

Potential antiviral peptides targeting the SARS-CoV-2 spike protein
by: Ibrahim Khater, et al.
Published: (2022-12-01)

Human ACE2 orthologous peptide sequences show better binding affinity to SARS-CoV-2 RBD domain: Implications for drug design
by: Lena Mahmoudi Azar, et al.
Published: (2023-01-01)

Site Density Functional Theory and Structural Bioinformatics Analysis of the SARS-CoV Spike Protein and hACE2 Complex
by: Nitesh Kumawat, et al.
Published: (2022-01-01)

Binding affinity between coronavirus spike protein and human ACE2 receptor
by: Marcus Ho-Hin Shum, et al.
Published: (2024-12-01)

Identifying promising druggable binding sites and their flexibility to target the receptor-binding domain of SARS-CoV-2 spike protein
by: M. Ghoula, et al.
Published: (2023-01-01)

Identification of hACE2-interacting sites in SARS-CoV-2 spike receptor binding domain for antiviral drugs screening
by: Xiaopeng Hu, et al.
Published: (2022-11-01)

Emergence of SARS‐CoV‐2 spike protein at the vaccination site
by: Annika Beck, et al.
Published: (2023-03-01)

The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies
by: Anastassios C. Papageorgiou, et al.
Published: (2020-10-01)

A Pathway Model to Understand the Evolution of Spike Protein Binding to ACE2 in SARS-CoV-2 Variants
by: Ludovico Pipitò, et al.
Published: (2022-10-01)

Calcium Binding Mechanism of Soybean Peptide with Histidine Alteration by Molecular Docking Analysis and Spectroscopic Methods
by: Jing Gan, et al.
Published: (2022-10-01)

Interference of Polydatin/Resveratrol in the ACE2:Spike Recognition during COVID-19 Infection. A Focus on Their Potential Mechanism of Action through Computational and Biochemical Assays
by: Fulvio Perrella, et al.
Published: (2021-07-01)

Omicron SARS-CoV-2 Variant Spike Protein Shows an Increased Affinity to the Human ACE2 Receptor: An In Silico Analysis
by: Joseph Thomas Ortega, et al.
Published: (2021-12-01)

Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation
by: Mohamed Hagras, et al.
Published: (2021-01-01)

Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2
by: Ma’mon M. Hatmal, et al.
Published: (2020-12-01)

Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization
by: Masaud Shah, et al.
Published: (2020-01-01)

Identifying epitopes for cluster of differentiation and design of new peptides inhibitors against human SARS-CoV-2 spike RBD by an in-silico approach
by: Jihane Akachar, et al.
Published: (2020-12-01)

Uncovering the impact of SARS-CoV2 spike protein variants on human receptors: A molecular dynamics docking and simulation approach
by: Muhammad Zaheer, et al.
Published: (2023-10-01)

Design of Three Residues Peptides against SARS-CoV-2 Infection
by: Carla Zannella, et al.
Published: (2022-09-01)

Decoy peptides effectively inhibit the binding of SARS-CoV-2 to ACE2 on oral epithelial cells
by: Lai-Keng Loi, et al.
Published: (2023-12-01)

Molecular docking between human TMPRSS2 and SARS-CoV-2 spike protein: conformation and intermolecular interactions
by: Mushtaq Hussain, et al.
Published: (2020-09-01)

Whey-Derived Peptides Interactions with ACE by Molecular Docking as a Potential Predictive Tool of Natural ACE Inhibitors
by: Yara Chamata, et al.
Published: (2020-01-01)

The Development of Pharmacophore Models for the Search of New Natural Inhibitors of SARS-CoV-2 Spike RBD–ACE2 Binding Interface
by: Valentin A. Semenov, et al.
Published: (2022-12-01)

Molecular docking of curcumin analogues as serca inhibitory agents
by: Liudmyla K. Sviatenko
Published: (2014-04-01)

Molecular docking of ZSTK474 derivatives as potential PI3K-delta inhibitory agents
by: Liudmyla K. Sviatenko, et al.
Published: (2014-12-01)

Novel Polymyxin-Inspired Peptidomimetics Targeting the SARS-CoV-2 Spike:hACE2 Interface
by: Kelly Bugatti, et al.
Published: (2023-05-01)

An Approach for Engineering Peptides for Competitive Inhibition of the SARS-COV-2 Spike Protein
by: Ana Paula de Abreu, et al.
Published: (2024-04-01)

Profiling of insulin and resveratrol interaction using multi-spectroscopy and molecular docking study
by: Sahri Yanti, et al.
Published: (2022-07-01)

SARS-CoV-2 Spike-Derived Peptides Presented by HLA Molecules
by: Andrea T. Nguyen, et al.
Published: (2021-05-01)

Identifying SARS-CoV-2 Drugs Binding to the Spike Fatty Acid Binding Pocket Using In Silico Docking and Molecular Dynamics
by: Sakshi Piplani, et al.
Published: (2023-02-01)

Prediction of protein-binding areas by small-world residue networks and application to docking
by: Glaser Fabian, et al.
Published: (2011-09-01)

Characterizations and molecular docking mechanism of the interactions between peptide FDGDF (Phe-Asp-Gly-Asp-Phe) and SOD enzyme
by: C.H.E.N. Wen-Tao, et al.
Published: (2024-01-01)

Structural and Molecular Docking Analytical Studies of the Predicted Ligand Binding Sites of Cadherin-1 in Cancer Prognostics
by: Bakare OO, et al.
Published: (2020-07-01)

Characterizations of a Food Decapeptide Chelating with Zn(II)
by: Weiwei Fan, et al.
Published: (2020-08-01)

Modelling peptide–protein complexes: docking, simulations and machine learning
by: Arup Mondal, et al.
Published: (2022-01-01)

<i>In silico</i> screening of chalcones and their derivatives as potential inhibitors of spike proteins and ACE2 enzymes for SARS-CoV-2 treatment
by: Thi Thu Hang Ta, et al.
Published: (2022-06-01)